235 related articles for article (PubMed ID: 16454829)
1. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
Thomas-Marques L; Murat A; Delemer B; Penfornis A; Cardot-Bauters C; Baudin E; Niccoli-Sire P; Levoir D; Choplin Hdu B; Chabre O; Jovenin N; Cadiot G;
Am J Gastroenterol; 2006 Feb; 101(2):266-73. PubMed ID: 16454829
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
Langer P; Kann PH; Fendrich V; Richter G; Diehl S; Rothmund M; Bartsch DK
World J Surg; 2004 Dec; 28(12):1317-22. PubMed ID: 15517479
[TBL] [Abstract][Full Text] [Related]
3. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
Kann PH; Balakina E; Ivan D; Bartsch DK; Meyer S; Klose KJ; Behr T; Langer P
Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1.
Hellman P; Hennings J; Akerström G; Skogseid B
Br J Surg; 2005 Dec; 92(12):1508-12. PubMed ID: 16231278
[TBL] [Abstract][Full Text] [Related]
5. Prospective controlled trial of a standardized meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1.
Langer P; Wild A; Celik I; Kopp I; Bergenfelz A; Bartsch DK
Br J Surg; 2001 Oct; 88(10):1403-7. PubMed ID: 11578300
[TBL] [Abstract][Full Text] [Related]
6. EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia.
Wamsteker EJ; Gauger PG; Thompson NW; Scheiman JM
Gastrointest Endosc; 2003 Oct; 58(4):531-5. PubMed ID: 14520285
[TBL] [Abstract][Full Text] [Related]
7. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.
Triponez F; Sadowski SM; Pattou F; Cardot-Bauters C; Mirallié E; Le Bras M; Sebag F; Niccoli P; Deguelte S; Cadiot G; Poncet G; Lifante JC; Borson-Chazot F; Chaffanjon P; Chabre O; Menegaux F; Baudin E; Ruszniewski P; Du Boullay H; Goudet P
Ann Surg; 2018 Jul; 268(1):158-164. PubMed ID: 28263205
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type I syndrome.
Dʼsouza SL; Elmunzer BJ; Scheiman JM
J Clin Gastroenterol; 2014; 48(5):458-61. PubMed ID: 24356459
[TBL] [Abstract][Full Text] [Related]
9. Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1.
Gauger PG; Scheiman JM; Wamsteker EJ; Richards ML; Doherty GM; Thompson NW
Br J Surg; 2003 Jun; 90(6):748-54. PubMed ID: 12808627
[TBL] [Abstract][Full Text] [Related]
10. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
[TBL] [Abstract][Full Text] [Related]
11. Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE.
Triponez F; Goudet P; Dosseh D; Cougard P; Bauters C; Murat A; Cadiot G; Niccoli-Sire P; Calender A; Proye CA;
World J Surg; 2006 May; 30(5):654-62; discussion 663-4. PubMed ID: 16680582
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
Polenta V; Slater EP; Kann PH; Albers MB; Manoharan J; Ramaswamy A; Mahnken AH; Bartsch DK
World J Surg; 2018 May; 42(5):1440-1447. PubMed ID: 29075857
[TBL] [Abstract][Full Text] [Related]
13. Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study.
Kappelle WF; Valk GD; Leenders M; Moons LM; Bogte A; Siersema PD; Vleggaar FP
Endoscopy; 2017 Jan; 49(1):27-34. PubMed ID: 27975336
[No Abstract] [Full Text] [Related]
14. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
[TBL] [Abstract][Full Text] [Related]
15. Screening of pancreaticoduodenal endocrine tumours in patients with MEN 1: multidetector-row computed tomography vs. endoscopic ultrasound.
Camera L; Paoletta S; Mollica C; Milone F; Napolitano V; De Luca L; Faggiano A; Colao A; Salvatore M
Radiol Med; 2011 Jun; 116(4):595-606. PubMed ID: 21286942
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1.
Barbe C; Murat A; Dupas B; Ruszniewski P; Tabarin A; Vullierme MP; Penfornis A; Rohmer V; Baudin E; Le Rhun M; Gaye D; Marcus C; Cadiot G;
Dig Liver Dis; 2012 Mar; 44(3):228-34. PubMed ID: 22078814
[TBL] [Abstract][Full Text] [Related]
17. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?
Bartsch DK; Langer P; Wild A; Schilling T; Celik I; Rothmund M; Nies C
Surgery; 2000 Dec; 128(6):958-66. PubMed ID: 11114630
[TBL] [Abstract][Full Text] [Related]
18. Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome.
Davì MV; Boninsegna L; Dalle Carbonare L; Toaiari M; Capelli P; Scarpa A; Francia G; Falconi M
Neuroendocrinology; 2011; 94(1):58-65. PubMed ID: 21464564
[TBL] [Abstract][Full Text] [Related]
19. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
[TBL] [Abstract][Full Text] [Related]
20. Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients.
de Laat JM; Pieterman CR; Weijmans M; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2013 Oct; 98(10):4143-51. PubMed ID: 23956349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
